Eric Thomas Greager, President and CEO, stated that Baytex delivered "solid operational and financial results in the second quarter that reflect the quality of our assets as well as our focus on ...
TEL AVIV, Israel, Sept. 27, 2022 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a pre-commercial-stage biopharmaceutical company focused on oncology, today announced its U.S.
In the fast-growing, ever-evolving world of pharmaceuticals, few sectors are as dynamic and promising as radiopharmaceuticals. Fueled by technological advancements and a growing demand for targeted ...
And I would now like to hand you over to your CEO, Peter Collins. Good afternoon to you. Thank you. Good afternoon. Peter Collins, CEO at CelLBxHealth. I'm looking forward to share the latest around ...
Bringing groundbreaking new drugs to market is no small feat. The journey begins with navigating a complex landscape of research and intellectual property to discover a viable and patentable candidate ...
Biolab Farmacêutica gains exclusive rights in Brazil to GMRx2, an innovative single pill combination of three medicines, including two doses that are lower than those currently available in single ...
Purdue University Northwest (PNW) will join the Chicago region’s Bloch Tech Hub, a coalition of industry, academic, government and nonprofit stakeholders led by the Chicago Quantum Exchange and its ...
Montreal, QC – TheNewswire - November 6, 2025 — Scandium Canada Ltd. (TSX-V: SCD) is pleased to update shareholders on the commercialization efforts of its patent-pending Aluminum-Scandium alloys ...
NEW YORK, NY / ACCESS Newswire / November 6, 2025 / SSHT S&T Group Ltd. (the "Company"), a technology-driven enterprise specializing in wireless communications and intelligent connectivity, today ...
VerifyU credentialing with patented ADIO & WiSA technologies to connect NFL alumni to benefits and statistical credentials, fans, venues and events with acoustic mobile quick response WiSA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results